Erick Lucera - Net Worth and Insider Trading
Erick Lucera Net Worth
The estimated net worth of Erick Lucera is at least $163,358 dollars as of 2024-12-26. Erick Lucera is the EVP, CHIEF FINANCIAL OFFICER of Editas Medicine Inc and owns about 116,829 shares of Editas Medicine Inc (EDIT) stock worth over $143,700. Erick Lucera is the Director of Beyond Air Inc and owns about 43,608 shares of Beyond Air Inc (XAIR) stock worth over $19,654. Erick Lucera is also the See Remarks of Valeritas Holdings Inc and owns about 225 shares of Valeritas Holdings Inc (VLRXQ) stock worth over $5. Details can be seen in Erick Lucera's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erick Lucera has not made any transactions after 2024-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Erick Lucera
Erick Lucera Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Erick Lucera owns 6 companies in total, including AVEO Pharmaceuticals Inc (AVEO) , Valeritas Holdings Inc (VLRXQ) , and Beyond Air Inc (XAIR) among others .
Click here to see the complete history of Erick Lucera’s form 4 insider trades.
Insider Ownership Summary of Erick Lucera
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVEO | AVEO Pharmaceuticals Inc | 2020-01-06 | Chief Financial Officer |
| VLRXQ | Valeritas Holdings Inc | 2019-03-07 | See Remarks |
| XAIR | Beyond Air Inc | 2024-08-14 | director |
 | | 2021-10-15 | director |
| | 2023-04-03 | director |
| | 2024-05-20 | EVP & CHIEF FINANCIAL OFFICER |
Erick Lucera Latest Holdings Summary
Erick Lucera currently owns a total of 3 stocks. Among these stocks, Erick Lucera owns 116,829 shares of Editas Medicine Inc (EDIT) as of May 20, 2024, with a value of $143,700 and a weighting of 87.97%. Erick Lucera owns 43,608 shares of Beyond Air Inc (XAIR) as of August 14, 2024, with a value of $19,654 and a weighting of 12.03%. Erick Lucera also owns 225 shares of Valeritas Holdings Inc (VLRXQ) as of May 22, 2017, with a value of $5 and a weighting of 0%.
Latest Holdings of Erick Lucera
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EDIT | Editas Medicine Inc | 2024-05-20 | 116,829 | 1.23 | 143,700 |
| XAIR | Beyond Air Inc | 2024-08-14 | 43,608 | 0.45 | 19,654 |
| VLRXQ | Valeritas Holdings Inc | 2017-05-22 | 225 | 0.02 | 5 |
Holding Weightings of Erick Lucera
Erick Lucera Form 4 Trading Tracker
According to the SEC Form 4 filings, Erick Lucera has made a total of 1 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Editas Medicine Inc is the sale of 22,337 shares on May 20, 2024, which brought Erick Lucera around $125,311.
According to the SEC Form 4 filings, Erick Lucera has made a total of 2 transactions in Beyond Air Inc (XAIR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Beyond Air Inc is the acquisition of 39,266 shares on August 14, 2024, which cost Erick Lucera around $15,706.
According to the SEC Form 4 filings, Erick Lucera has made a total of 0 transactions in Valeritas Holdings Inc (VLRXQ) over the past 5 years. The most-recent trade in Valeritas Holdings Inc is the acquisition of 75 shares on May 22, 2017, which cost Erick Lucera around $7,425.
Insider Trading History of Erick Lucera
- 1
Erick Lucera Trading Performance
GuruFocus tracks the stock performance after each of Erick Lucera's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erick Lucera is -8.68%. GuruFocus also compares Erick Lucera's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erick Lucera within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Erick Lucera's insider trading performs compared to the benchmark.
Performance of Erick Lucera
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.19 | | | | | |
| Relative Return to S&P 500(%) | -3.55 | | | | | |
Erick Lucera Ownership Network
Erick Lucera Owned Company Details
What does AVEO Pharmaceuticals Inc do?
Who are the key executives at AVEO Pharmaceuticals Inc?
Erick Lucera is the Chief Financial Officer of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .
AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVEO Pharmaceuticals Inc Insider Transactions
Erick Lucera Mailing Address
Above is the net worth, insider trading, and ownership report for Erick Lucera. You might contact Erick Lucera via mailing address: 138 Thistle Road, North Andover Ma 08145.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
